Allarity Therapeutics
ALLR
20 hedge funds and large institutions have $1.65M invested in Allarity Therapeutics in 2026 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
59% more capital invested
Capital invested by funds: $1.04M → $1.65M (+$616K)
43% more funds holding
Funds holding: 14 → 20 (+6)
2.14% more ownership
Funds ownership: 5.91% → 8.05% (+2.1%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$147K |
| 2 |
MCM
Militia Capital Management
Austin,
Texas
|
+$140K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$130K |
| 4 |
HF
HRT Financial
New York
|
+$52.5K |
| 5 |
Jane Street
New York
|
+$51.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$50.4K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$16.4K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$13.4K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$11.5K |
| 5 |
Citigroup
New York
|
-$8.46K |
ALLR Hedge Fund Activity: Q2 2026 in Review
20 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in Allarity Therapeutics (ALLR) for Q2 2026, worth a combined $1.65M — up 59% from $1.04M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ALLR positions and 2 closed out — a net gain of 6 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $147K. The largest seller was Geode Capital Management, cutting an estimated $50.4K.
- 20 institutional investors held Allarity Therapeutics (ALLR) as of Q2 2026, up from 14 in Q1 2026.
- Funds reported $1.65M of Allarity Therapeutics stock for Q2 2026, up 59% quarter-over-quarter.
- 8 funds opened new Allarity Therapeutics positions in Q2 2026 and 2 closed out, a net change of +6 holders.
- The largest Allarity Therapeutics buyer in Q2 2026 was Renaissance Technologies, an estimated $147K added.
- The largest Allarity Therapeutics seller in Q2 2026 was Geode Capital Management, an estimated $50.4K sold.
Based on aggregated 13F filings for Q2 2026.